Click amount to donate direct to CounterPunch
  • $25
  • $50
  • $100
  • $500
  • $other
  • use PayPal
Spring Fund Drive: Keep CounterPunch Afloat
CounterPunch is a lifeboat of sanity in today’s turbulent political seas. Please make a tax-deductible donation and help us continue to fight Trump and his enablers on both sides of the aisle. Every dollar counts!
FacebookTwitterGoogle+RedditEmail

African Babies as Guinea Pigs?

When it comes to the new malaria vaccine developed by  GlaxoSmithKline (GSK) now being tested on infants in the east African country of Tanzania I will let the words of an industry insider tell it best:

“There is not much profit to be made by big pharma from a highly effective malaria vaccine of practical use for African sufferers…they [Big Drugs) are fiendishly clever at exploiting any and all opportunities to reap big benefits.”

“The poorly performing malaria vaccine RTS,S, created by GSK with a healthy infusion of funds from the Gates Foundation, is being tested in Phase III trials in Africa now. Including many thousands of African infants.”

“GSK will not profit from RTS,S. However, RTS,S is injected along with a new GSK adjuvant called AS01.”

“GSK will make vast sums from the new adjuvant, the testing of which is being piggybacked on their altruistic malaria vaccine (which, incidentally, is virtually entirely ineffective without AS01).”

“Interestingly, RTS,S (or should I say, AS01) testing in African infants began before AS01 trials in children were permitted in the United States.”

“GSK physician-scientists also held positions of significance in the Gates Foundation…conflict-of-interest issues not withstanding.”

So the Gates Foundation is giving Big Bucks ($400 million and counting) to Big Drugs/GSK to develop a vaccine against Africa’s number one killer, malaria.

The new not-for-profit malaria vaccine is “virtually entirely ineffective” without another medicine, whose patent is owned by GSK, resulting in $billions of African blood money filling the coffers of Big Drugs, once again.

Never mind Big Drugs/GSK had its reps at the Gate$ Foundation and Big Buck$ in the form of tax deductible grants are being shelled out by the Gate$ Foundation to Big Drugs/GSK.

And never mind that billions of desperately needed African foreign currency reserves will be spent on this new malaria vaccine. The really nasty thing about all this is the fact that, once again, Big Drugs tests new drugs on African babies before any such permission is granted to do so on American babies.

And all the while one African country, Eritrea, has reduced malaria mortality by 80% over the last decade, a fact unknown to the supposedly altruistic, or more aptly, incestuous, vaccine industry.

Thomas C. Mountain is the only independent western journalist in the Horn of Africa, living and reporting from Eritrea since 2006. He can be reached at thomascmountain at yahoo dot com. 

More articles by:

Thomas C. Mountain attended Punahou School for six years some half a dozen years before “Barry O’Bombers” time there. He has been living and writing from Eritrea since 2006. He can be reached at thomascmountain at g_ mail_ dot _com

May 21, 2018
Ron Jacobs
Gina Haspell: She’s Certainly Qualified for the Job
Uri Avnery
The Day of Shame
Amitai Ben-Abba
Israel’s New Ideology of Genocide
Patrick Cockburn
Israel is at the Height of Its Power, But the Palestinians are Still There
Frank Stricker
Can We Finally Stop Worrying About Unemployment?
Binoy Kampmark
Royal Wedding Madness
Roy Morrison
Middle East War Clouds Gather
Edward Curtin
Gina Haspel and Pinocchio From Rome
Juana Carrasco Martin
The United States is a Country Addicted to Violence
Dean Baker
Wealth Inequality: It’s Not Clear What It Means
Robert Dodge
At the Brink of Nuclear War, Who Will Lead?
Vern Loomis
If I’m Lying, I’m Dying
Valerie Reynoso
How LBJ initiated the Military Coup in the Dominican Republic
Weekend Edition
May 18, 2018
Friday - Sunday
Andrew Levine
The Donald, Vlad, and Bibi
Robert Fisk
How Long Will We Pretend Palestinians Aren’t People?
Jeffrey St. Clair
Wild at Heart: Keeping Up With Margie Kidder
Roger Harris
Venezuela on the Eve of Presidential Elections: The US Empire Isn’t Sitting by Idly
Michael Slager
Criminalizing Victims: the Fate of Honduran Refugees 
John Laforge
Don’t Call It an Explosion: Gaseous Ignition Events with Radioactive Waste
Carlo Filice
The First “Fake News” Story (or, What the Serpent Would Have Said)
Dave Lindorff
Israel Crosses a Line as IDF Snipers Murder Unarmed Protesters in the Ghetto of Gaza
Gary Leupp
The McCain Cult
Robert Fantina
What’s Wrong With the United States?
Jill Richardson
The Lesson I Learned Growing Up Jewish
David Orenstein
A Call to Secular Humanist Resistance
W. T. Whitney
The U.S. Role in Removing a Revolutionary and in Restoring War to Colombia
Rev. William Alberts
The Danger of Praying Truth to Power
Alan Macleod
A Primer on the Venezuelan Elections
John W. Whitehead
The Age of Petty Tyrannies
Franklin Lamb
Have Recent Events Sounded the Death Knell for Iran’s Regional Project?
Brian Saady
How the “Cocaine Mitch” Saga Deflected the Spotlight on Corruption
David Swanson
Tim Kaine’s War Scam Hits a Speed Bump
Norah Vawter
Pipeline Outrage is a Human Issue, Not a Political Issue
Mel Gurtov
Who’s to Blame If the US-North Korea Summit Isn’t Held?
Patrick Bobilin
When Outrage is Capital
Jessicah Pierre
The Moral Revolution America Needs
Binoy Kampmark
Big Dead Place: Remembering Antarctica
John Carroll Md
What Does It Mean to be a Physician Advocate in Haiti?
George Ochenski
Saving Sage Grouse: Another Collaborative Failure
Sam Husseini
To the US Government, Israel is, Again, Totally Off The Hook
Brian Wakamo
Sick of Shady Banks? Get a Loan from the Post Office!
Colin Todhunter
Dangerous Liaison: Industrial Agriculture and the Reductionist Mindset
Ralph Nader
Trump: Making America Dread Again
George Capaccio
Bloody Monday, Every Day of the Week
Barbara Nimri Aziz
Swing Status, Be Gone
FacebookTwitterGoogle+RedditEmail